Search Results 911-920 of 13930 for Assay

  1. Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer - Mayo Clinic

    mutation) (MAF) less than 2% by Guardant360 assay. - Detection of at least one of the following gene mutation(s) or amplification(s) by. Guardant360 assay.

  2. Pharmacogenomics in patient care - Center for Individualized Medicine - Mayo Clinic Research

    The Mayo Clinic Center for Individualized Medicine offers pharmacogenomic testing to better understand how your genes affect your body's response to ...

  3. Isatuximab In Treating Patients With Relapsed Or Refractory Primary Amyloidosis - Mayo Clinic

    Patient has undetectable HIV viral load by standard PCR clinical assay;; Patient is willing to maintain adherence to combination antiretroviral therapy ...

  4. A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma or non-Hodgkin Lymphoma - Mayo Clinic

    Serum FLC assay result with an involved FLC level ≥ 10 mg/dL (≥ 100 milligram per liter [mg/L]), provided the serum FLC ratio is abnormal. Eastern ...

  5. A Study to Evaluate Molecular and Biochemical Testing for Suspected Hereditary Disorders - Mayo Clinic

    ... assay such as methylation-sensitive MLPA; borderline droplet count or copy number detected by ddPCR or qPCR, respectively;; A single mutation identified in a ...

  6. Cholesterol test - Mayo Clinic

    It can measure the amount of cholesterol and fats called triglycerides in blood. This test also is called a lipid panel or a lipid profile. A cholesterol test ...

  7. Beating the beast: Mayo Clinic's pediatric urologists and their sarcoma team's mission to cure rhabdomyosarcoma

    Mayo Clinic investigators have developed a 3D microcancer assay, growing microtumors from patient tissue. By studying drug responses to these microtumors ...

  8. A Study Of Elecsys IGRA TB Test System - Mayo Clinic

    The purpose of this study is to investigate the clinical performance of Elecsys IGRA TB Test System in detecting Mycobacterium tuberculosis (M. tb) infections ...

  9. Uncovering Signaling Pathways That Regulate Invasion and Metastasis of Cancer Cells - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

    Current research in the laboratory focuses on developing assays that can be clinically used to determine PKD1 and PKD3 expression in patient samples. The ...

  10. blood test Archives - Mayo Clinic News Network

    ... assays and develops novel therapeutics to improve survival in early-stage and metastatic breast cancer. Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden ...